Submitted by Anonymous (not verified) on 15 April 2026 - 11:22
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 16, Status: Authorised